Latest News

2 new influenza strains recommended for next season


 

REPORTING FROM AN FDA ADVISORY COMMITTEE MEETING

The CDC estimate of current vaccine effectiveness (VE) against influenza A (H3N2) viruses is 25%, as of Feb. 3. Effectiveness is even higher for all influenza viruses, with an estimated VE of 36%, indicating that the flu vaccine reduced a person’s risk of having to seek medical care at a doctor’s office for flu illness by 36% ( MMWR. 2018;67:180-5 ).

While the FDA usually follows the recommendations of its panel members, it is not obligated to do so. None of the committee members disclosed relevant financial conflicts of interest.

Pages

Recommended Reading

FDA warns against clarithromycin use in patients with heart disease
MDedge Internal Medicine
Flu season shows signs of slowing
MDedge Internal Medicine
Combo therapy does not improve outcomes for A. Baumannii
MDedge Internal Medicine
HCV infection tied to premature ovarian senescence and a high miscarriage rate
MDedge Internal Medicine
NASH rapidly overtaking hepatitis C as cause of liver cancer
MDedge Internal Medicine
VIDEO: The return of Kaposi’s sarcoma
MDedge Internal Medicine
Preoperative penicillin allergy tests could decrease SSI
MDedge Internal Medicine
Vaccines: Effectiveness vs. efficacy
MDedge Internal Medicine
Increasing sepsis survivorship creates new challenges
MDedge Internal Medicine
Hydrocortisone-fludrocortisone cuts deaths in septic shock
MDedge Internal Medicine